# Efficacy of the Use of Vasopressin as a Primary Vasoconstrictor in Critically Ill Patients

> **NCT06265259** · PHASE4 · UNKNOWN · sponsor: **University of Thessaly** · enrollment: 145 (estimated)

## Conditions studied

- Circulatory Shock

## Interventions

- **DRUG:** Initiation of vasopressine as a first vasoconstrictive drug
- **DRUG:** Initiation of noradrenaline as a first vasoconstrictive drug

## Key facts

- **NCT ID:** NCT06265259
- **Lead sponsor:** University of Thessaly
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-12-15
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-01-31
- **Target enrollment:** 145 (ESTIMATED)
- **Last updated:** 2024-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06265259

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06265259, "Efficacy of the Use of Vasopressin as a Primary Vasoconstrictor in Critically Ill Patients". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06265259. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*